Lishun Zhang

Discovery of 4-methyl-3-(pyridin-2-ylamino)benzamide derivatives as C-Abl inhibitors with potential neuroprotective effect.

Zhonghuang Li, Jiajie Zhang, Zichao Yang, 2022, Bioorganic & medicinal chemistry.

Computational Studies of Potent Covalent Inhibitors on Wild Type or T790M/L858R Mutant Epidermal Growth Factor Receptor.

Zhonghuang Li, Jiajie Zhang, Zichao Yang, 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Identification of imidazo[4,5-c]pyridin-2-one derivatives as novel Src family kinase inhibitors against glioblastoma

Jiajie Zhang, Zichao Yang, Tingting Zhang, 2021, Journal of enzyme inhibition and medicinal chemistry.

B13, a well-tolerated inhibitor of hedgehog pathway, exhibited potent anti-tumor effects against colorectal carcinoma in vitro and in vivo.

Yuan-xin Tian, Jiajie Zhang, Tingting Zhang, 2023, Bioorganic chemistry.

Discovery of conformationally constrained c-Abl inhibitors with potential neuroprotective effects against Parkinson's disease.

Jiajie Zhang, Zichao Yang, Tingting Zhang, 2023, Bioorganic & medicinal chemistry.

The cytochrome P450 metabolic profiling of SMU-B in vitro, a novel small molecule tyrosine kinase inhibitor.

Zhonghuang Li, Jiajie Zhang, Zhengguang Zhu, 2020, Journal of pharmaceutical and biomedical analysis.